News

The internet-based initiative, supported by Scripps Research Institute and IBM, will link participating computers to a grid which will utilize the power of each individual machine for various

The efficacy of the drug as a treatment for panic disorder was established in two 12-week, placebo-controlled studies. Adult patients received fixed doses of 75 or 150mg/day in

Wyeth has agreed to extend the research term by one year to February 9, 2007. Curis expects Wyeth to select a development candidate in the next twelve to

Ethos I stents are coated with slow-release and moderate-release formulations of 17 beta-estradiol, an approved drug used in hormone replacement therapy and other indications. The trial is a

Pfizer has gained exclusive worldwide development and commercialization rights to Incyte’s portfolio of CCR2 antagonist compounds, the most advanced of which is currently in phase IIa studies in

The randomized, placebo controlled multi-center clinical trial is designed to evaluate both objective parameters, such as improvement in urine flow and shrinkage of the prostate volume, as well

The FDA grants priority review to products it believes represent a therapeutic advance over existing medicines. By granting priority review status to Cubicin, the FDA has established a

According to the company, this financing will result in net proceeds to Solexa of approximately $61 million after deduction of offering expenses. Under the terms of the financing,

Tamiflu was already scheduled to be reviewed after it was approved for use in children in March 2004, but the evaluation took on greater significance following the deaths